Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9225)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 15, 2020 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sabeti Aghabozorgi A, Moradi Sarabi M, Jafarzadeh-Esfehani R, Koochakkhani S, Hassanzadeh M, Kavousipour S, Eftekhar E. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids. World J Gastrointest Oncol 2020; 12(9): 942-956 [PMID: 33005290 DOI: 10.4251/wjgo.v12.i9.942] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v12/i9/942.htm |
| Number | Citing Articles |
| 1 |
Cailan Li, Jianhui Xie, Jiahao Wang, Ying Cao, Min Pu, Qihai Gong, Qiang Lu. Therapeutic effects and mechanisms of plant-derived natural compounds against intestinal mucositis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.969550
|
| 2 |
Chun-Chun Huang, Le-Qian Ying, Yan-Ping Chen, Min Ji, Lu Zhang, Lin Liu. Metachronous primary esophageal squamous cell carcinoma and duodenal adenocarcinoma: A case report and review of literature. World Journal of Gastrointestinal Surgery 2023; 15(11): 2627-2638 doi: 10.4240/wjgs.v15.i11.2627
Abstract(365) |
Core Tip(336) |
Full Article(HTML)(1060)
|
Full Article with Cover (PDF)-3970K(51)
|
Full Article (Word)-868K(31)
|
Audio-1464K(5)
|
Peer-Review Report-248K(46)
|
Answering Reviewers-330K(44)
|
Full Article (PDF)-3712K(79)
|
Full Article (XML)-148K(44)
|
Times Cited (0)
|
Total Visits (3772)
|
Open
|
| 3 |
Laura Grumetti, Rita Lombardi, Federica Iannelli, Biagio Pucci, Antonio Avallone, Elena Di Gennaro, Alfredo Budillon. Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors. Cancers 2022; 14(3): 695 doi: 10.3390/cancers14030695
|
| 4 |
Saihong Yu, Zhuduo Li, Linglan Tu, Yiyi Pu, Dongmei Yan, Xiaoju Wang, Xiaoliang Zheng, Jie Yu. Uricase sensitizes hepatocellular carcinoma cells to 5-fluorouracil through uricase-uric acid-UMP synthase axis. Journal of Physiology and Biochemistry 2022; 78(3): 679 doi: 10.1007/s13105-022-00894-5
|
| 5 |
Seyed Hamid Moosavy, Shabnaz Koochakkhani, Mahdi Barazesh, Shiva Mohammadi, Khadijeh Ahmadi, Behnaz Rahnama Inchehsablagh, Soudabeh Kavousipour, Ebrahim Eftekhar, Pooneh Mokaram. In silico Analysis of Single Nucleotide Polymorphisms Associated with MicroRNA
Regulating 5-fluorouracil Resistance in Colorectal Cancer. Letters in Drug Design & Discovery 2022; 19(2): 144 doi: 10.2174/1570180818666210930161618
|
| 6 |
Yang Gao, Chen Liu, Xiaoyun Xu, Yijing Wang, Yuanyuan Jiang. Circular RNA sterile alpha motif domain containing 4A contributes to cell 5-fluorouracil resistance in colorectal cancer by regulating the miR-545-3p/6-phosphofructo-2-kinase/fructose-2,6-bisphosphataseisotype 3 axis. Anti-Cancer Drugs 2022; 33(6): 553 doi: 10.1097/CAD.0000000000001285
|
| 7 |
Austin A. Saugstad, Natasha Petry, Catherine Hajek. Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.857120
|
| 8 |
Shiekhah Alzahrani, Huda Al Doghaither, Ayat Al‑ghafari, Peter Pushparaj. 5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review). Oncology Reports 2023; 50(4) doi: 10.3892/or.2023.8612
|
| 9 |
Leila Mousazadeh, Behzad Mousazadeh, Jamshid Motaei, Faezeh Abbasi, Reza Jafarzadeh Esfehani. Preclinical and Clinical Aspects of using Tazemetostate in Human Cancers. Current Pharmaceutical Design 2022; 28(16): 1329 doi: 10.2174/1381612828666220408121514
|
| 10 |
Paulína Pidíková, Iveta Herichová. miRNA Clusters with Up-Regulated Expression in Colorectal Cancer. Cancers 2021; 13(12): 2979 doi: 10.3390/cancers13122979
|
| 11 |
Teppei Miyakawa, Hidetaka Kawamura, Michitaka Honda, Yoshinao Takano, Shunji Kinuta, Takahiro Kamiga, Shigeru Yamazaki, Atsushi Muto, Satoru Shiraso, Naoyuki Yamashita, Toshiyasu Iwao, Koji Kono, Shinichi Konno, Wen-Chi Chou. Impact of histological subtype on prognosis in stage IV colorectal cancer: A population-based cohort study. PLOS ONE 2022; 17(3): e0264652 doi: 10.1371/journal.pone.0264652
|